Importance of Patient-Reported Outcomes in Oncology Studies
Patient-reported outcomes (PROs) are widely used in oncology clinical trials to capture patients' own perspectives on symptoms, functioning, and quality of life.
These data are usually collected at multiple timepoints, sometimes weekly or even daily, requiring ongoing effort and engagement from study participants.
Modernizing Patient-Reported Outcomes: Bridging the Gap Between Legacy Measures and Contemporary Healthcare
The Need for Active Use of PRO Data
In most oncology trials, PRO data are not looked at while the study is ongoing, highlighting the need for more active use of this data.
- Advancing toward more meaningful use of PRO data by making it systematic, transparent, and built into trial design.
- Rethinking Oncology Trials With a Statistical Methodology That Puts Patients First
- Digital Measures of Health: What’s in It for Patients?
Author's summary: Improving oncology trials with patient-reported outcomes.